 | • レポートコード：MRC2-11QY04208 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は経皮的冠動脈インターベンションのグローバル市場について調査・分析したレポートです。種類別（薬剤溶出性ステント、ベアメタルステント、生体吸収性ステント）市場規模、用途別（病院、医療センター、神経学研究センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別経皮的冠動脈インターベンションの競争状況、市場シェア ・世界の経皮的冠動脈インターベンション市場：種類別市場規模 2015年-2020年（薬剤溶出性ステント、ベアメタルステント、生体吸収性ステント） ・世界の経皮的冠動脈インターベンション市場：種類別市場規模予測 2021年-2026年（薬剤溶出性ステント、ベアメタルステント、生体吸収性ステント） ・世界の経皮的冠動脈インターベンション市場：用途別市場規模 2015年-2020年（病院、医療センター、神経学研究センター） ・世界の経皮的冠動脈インターベンション市場：用途別市場規模予測 2021年-2026年（病院、医療センター、神経学研究センター） ・北米の経皮的冠動脈インターベンション市場分析：米国、カナダ ・ヨーロッパの経皮的冠動脈インターベンション市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの経皮的冠動脈インターベンション市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の経皮的冠動脈インターベンション市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの経皮的冠動脈インターベンション市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Vascular、Svelte Medical、Medtronic、Boston Scientific、Sysmetis、Cardiac Dimensions、Edwards Lifesciences、Acrostak ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Percutaneous coronary intervention (PCI) is a non-surgical procedure used to treat narrowing (stenosis) of the coronary arteries of the heart found in coronary artery disease. After accessing the blood stream through the femoral or radial artery, the procedure uses coronary catheterization to visualize the blood vessels on X-ray imaging. After this, an interventional cardiologist can perform a coronary angioplasty, using a balloon catheter in which a deflated balloon is advanced into the obstructed artery and inflated to relieve the narrowing; certain devices such as stents can be deployed to keep the blood vessel open.
PCI is used primarily to open a blocked coronary artery and restore arterial blood flow to heart tissue, without requiring open-heart surgery. In patients with a restricted or blocked coronary artery, PCI may be the best option to re-establish blood flow as well as prevent angina (chest pain), myocardial infarctions (heart attacks) and death. Today, PCI usually includes the insertion of stents, such as bare-metal stents, drug-eluting stents, and fully resorbable vascular scaffolds (or naturally dissolving stents).
Market Analysis and Insights: Global Percutaneous Coronary Intervention Market
The global Percutaneous Coronary Intervention market size is projected to reach US$ 11370 million by 2026, from US$ 10900 million in 2020, at a CAGR of 4.0%% during 2021-2026.
Global Percutaneous Coronary Intervention Scope and Market Size
Percutaneous Coronary Intervention market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Percutaneous Coronary Intervention market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Vascular
Svelte Medical
Medtronic
Boston Scientific
Sysmetis
Cardiac Dimensions
Edwards Lifesciences
Acrostak
Market segment by Type, the product can be split into
Drug-Eluting Stents
Bare Metal Stents
Bioresorbable Stents
Market segment by Application, split into
Hospitals
Healthcare Centers
Neurological Research Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Percutaneous Coronary Intervention Revenue
1.4 Market by Type
1.4.1 Global Percutaneous Coronary Intervention Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Drug-Eluting Stents
1.4.3 Bare Metal Stents
1.4.4 Bioresorbable Stents
1.5 Market by Application
1.5.1 Global Percutaneous Coronary Intervention Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Healthcare Centers
1.5.4 Neurological Research Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Percutaneous Coronary Intervention Market Perspective (2015-2026)
2.2 Global Percutaneous Coronary Intervention Growth Trends by Regions
2.2.1 Percutaneous Coronary Intervention Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Percutaneous Coronary Intervention Historic Market Share by Regions (2015-2020)
2.2.3 Percutaneous Coronary Intervention Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Percutaneous Coronary Intervention Market Growth Strategy
2.3.6 Primary Interviews with Key Percutaneous Coronary Intervention Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Percutaneous Coronary Intervention Players by Market Size
3.1.1 Global Top Percutaneous Coronary Intervention Players by Revenue (2015-2020)
3.1.2 Global Percutaneous Coronary Intervention Revenue Market Share by Players (2015-2020)
3.1.3 Global Percutaneous Coronary Intervention Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Percutaneous Coronary Intervention Market Concentration Ratio
3.2.1 Global Percutaneous Coronary Intervention Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Percutaneous Coronary Intervention Revenue in 2019
3.3 Percutaneous Coronary Intervention Key Players Head office and Area Served
3.4 Key Players Percutaneous Coronary Intervention Product Solution and Service
3.5 Date of Enter into Percutaneous Coronary Intervention Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Percutaneous Coronary Intervention Historic Market Size by Type (2015-2020)
4.2 Global Percutaneous Coronary Intervention Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Percutaneous Coronary Intervention Market Size by Application (2015-2020)
5.2 Global Percutaneous Coronary Intervention Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Percutaneous Coronary Intervention Market Size (2015-2020)
6.2 Percutaneous Coronary Intervention Key Players in North America (2019-2020)
6.3 North America Percutaneous Coronary Intervention Market Size by Type (2015-2020)
6.4 North America Percutaneous Coronary Intervention Market Size by Application (2015-2020)
7 Europe
7.1 Europe Percutaneous Coronary Intervention Market Size (2015-2020)
7.2 Percutaneous Coronary Intervention Key Players in Europe (2019-2020)
7.3 Europe Percutaneous Coronary Intervention Market Size by Type (2015-2020)
7.4 Europe Percutaneous Coronary Intervention Market Size by Application (2015-2020)
8 China
8.1 China Percutaneous Coronary Intervention Market Size (2015-2020)
8.2 Percutaneous Coronary Intervention Key Players in China (2019-2020)
8.3 China Percutaneous Coronary Intervention Market Size by Type (2015-2020)
8.4 China Percutaneous Coronary Intervention Market Size by Application (2015-2020)
9 Japan
9.1 Japan Percutaneous Coronary Intervention Market Size (2015-2020)
9.2 Percutaneous Coronary Intervention Key Players in Japan (2019-2020)
9.3 Japan Percutaneous Coronary Intervention Market Size by Type (2015-2020)
9.4 Japan Percutaneous Coronary Intervention Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Percutaneous Coronary Intervention Market Size (2015-2020)
10.2 Percutaneous Coronary Intervention Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Percutaneous Coronary Intervention Market Size by Type (2015-2020)
10.4 Southeast Asia Percutaneous Coronary Intervention Market Size by Application (2015-2020)
11 India
11.1 India Percutaneous Coronary Intervention Market Size (2015-2020)
11.2 Percutaneous Coronary Intervention Key Players in India (2019-2020)
11.3 India Percutaneous Coronary Intervention Market Size by Type (2015-2020)
11.4 India Percutaneous Coronary Intervention Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Percutaneous Coronary Intervention Market Size (2015-2020)
12.2 Percutaneous Coronary Intervention Key Players in Central & South America (2019-2020)
12.3 Central & South America Percutaneous Coronary Intervention Market Size by Type (2015-2020)
12.4 Central & South America Percutaneous Coronary Intervention Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Vascular
13.1.1 Abbott Vascular Company Details
13.1.2 Abbott Vascular Business Overview
13.1.3 Abbott Vascular Percutaneous Coronary Intervention Introduction
13.1.4 Abbott Vascular Revenue in Percutaneous Coronary Intervention Business (2015-2020))
13.1.5 Abbott Vascular Recent Development
13.2 Svelte Medical
13.2.1 Svelte Medical Company Details
13.2.2 Svelte Medical Business Overview
13.2.3 Svelte Medical Percutaneous Coronary Intervention Introduction
13.2.4 Svelte Medical Revenue in Percutaneous Coronary Intervention Business (2015-2020)
13.2.5 Svelte Medical Recent Development
13.3 Medtronic
13.3.1 Medtronic Company Details
13.3.2 Medtronic Business Overview
13.3.3 Medtronic Percutaneous Coronary Intervention Introduction
13.3.4 Medtronic Revenue in Percutaneous Coronary Intervention Business (2015-2020)
13.3.5 Medtronic Recent Development
13.4 Boston Scientific
13.4.1 Boston Scientific Company Details
13.4.2 Boston Scientific Business Overview
13.4.3 Boston Scientific Percutaneous Coronary Intervention Introduction
13.4.4 Boston Scientific Revenue in Percutaneous Coronary Intervention Business (2015-2020)
13.4.5 Boston Scientific Recent Development
13.5 Sysmetis
13.5.1 Sysmetis Company Details
13.5.2 Sysmetis Business Overview
13.5.3 Sysmetis Percutaneous Coronary Intervention Introduction
13.5.4 Sysmetis Revenue in Percutaneous Coronary Intervention Business (2015-2020)
13.5.5 Sysmetis Recent Development
13.6 Cardiac Dimensions
13.6.1 Cardiac Dimensions Company Details
13.6.2 Cardiac Dimensions Business Overview
13.6.3 Cardiac Dimensions Percutaneous Coronary Intervention Introduction
13.6.4 Cardiac Dimensions Revenue in Percutaneous Coronary Intervention Business (2015-2020)
13.6.5 Cardiac Dimensions Recent Development
13.7 Edwards Lifesciences
13.7.1 Edwards Lifesciences Company Details
13.7.2 Edwards Lifesciences Business Overview
13.7.3 Edwards Lifesciences Percutaneous Coronary Intervention Introduction
13.7.4 Edwards Lifesciences Revenue in Percutaneous Coronary Intervention Business (2015-2020)
13.7.5 Edwards Lifesciences Recent Development
13.8 Acrostak
13.8.1 Acrostak Company Details
13.8.2 Acrostak Business Overview
13.8.3 Acrostak Percutaneous Coronary Intervention Introduction
13.8.4 Acrostak Revenue in Percutaneous Coronary Intervention Business (2015-2020)
13.8.5 Acrostak Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Percutaneous Coronary Intervention Key Market Segments
Table 2. Key Players Covered: Ranking by Percutaneous Coronary Intervention Revenue
Table 3. Ranking of Global Top Percutaneous Coronary Intervention Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Percutaneous Coronary Intervention Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Drug-Eluting Stents
Table 6. Key Players of Bare Metal Stents
Table 7. Key Players of Bioresorbable Stents
Table 8. Global Percutaneous Coronary Intervention Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Percutaneous Coronary Intervention Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Percutaneous Coronary Intervention Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Percutaneous Coronary Intervention Market Share by Regions (2015-2020)
Table 12. Global Percutaneous Coronary Intervention Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Percutaneous Coronary Intervention Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Percutaneous Coronary Intervention Market Growth Strategy
Table 18. Main Points Interviewed from Key Percutaneous Coronary Intervention Players
Table 19. Global Percutaneous Coronary Intervention Revenue by Players (2015-2020) (Million US$)
Table 20. Global Percutaneous Coronary Intervention Market Share by Players (2015-2020)
Table 21. Global Top Percutaneous Coronary Intervention Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Percutaneous Coronary Intervention as of 2019)
Table 22. Global Percutaneous Coronary Intervention by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Percutaneous Coronary Intervention Product Solution and Service
Table 25. Date of Enter into Percutaneous Coronary Intervention Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Percutaneous Coronary Intervention Market Size by Type (2015-2020) (Million US$)
Table 28. Global Percutaneous Coronary Intervention Market Size Share by Type (2015-2020)
Table 29. Global Percutaneous Coronary Intervention Revenue Market Share by Type (2021-2026)
Table 30. Global Percutaneous Coronary Intervention Market Size Share by Application (2015-2020)
Table 31. Global Percutaneous Coronary Intervention Market Size by Application (2015-2020) (Million US$)
Table 32. Global Percutaneous Coronary Intervention Market Size Share by Application (2021-2026)
Table 33. North America Key Players Percutaneous Coronary Intervention Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Percutaneous Coronary Intervention Market Share (2019-2020)
Table 35. North America Percutaneous Coronary Intervention Market Size by Type (2015-2020) (Million US$)
Table 36. North America Percutaneous Coronary Intervention Market Share by Type (2015-2020)
Table 37. North America Percutaneous Coronary Intervention Market Size by Application (2015-2020) (Million US$)
Table 38. North America Percutaneous Coronary Intervention Market Share by Application (2015-2020)
Table 39. Europe Key Players Percutaneous Coronary Intervention Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Percutaneous Coronary Intervention Market Share (2019-2020)
Table 41. Europe Percutaneous Coronary Intervention Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Percutaneous Coronary Intervention Market Share by Type (2015-2020)
Table 43. Europe Percutaneous Coronary Intervention Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Percutaneous Coronary Intervention Market Share by Application (2015-2020)
Table 45. China Key Players Percutaneous Coronary Intervention Revenue (2019-2020) (Million US$)
Table 46. China Key Players Percutaneous Coronary Intervention Market Share (2019-2020)
Table 47. China Percutaneous Coronary Intervention Market Size by Type (2015-2020) (Million US$)
Table 48. China Percutaneous Coronary Intervention Market Share by Type (2015-2020)
Table 49. China Percutaneous Coronary Intervention Market Size by Application (2015-2020) (Million US$)
Table 50. China Percutaneous Coronary Intervention Market Share by Application (2015-2020)
Table 51. Japan Key Players Percutaneous Coronary Intervention Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Percutaneous Coronary Intervention Market Share (2019-2020)
Table 53. Japan Percutaneous Coronary Intervention Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Percutaneous Coronary Intervention Market Share by Type (2015-2020)
Table 55. Japan Percutaneous Coronary Intervention Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Percutaneous Coronary Intervention Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Percutaneous Coronary Intervention Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Percutaneous Coronary Intervention Market Share (2019-2020)
Table 59. Southeast Asia Percutaneous Coronary Intervention Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Percutaneous Coronary Intervention Market Share by Type (2015-2020)
Table 61. Southeast Asia Percutaneous Coronary Intervention Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Percutaneous Coronary Intervention Market Share by Application (2015-2020)
Table 63. India Key Players Percutaneous Coronary Intervention Revenue (2019-2020) (Million US$)
Table 64. India Key Players Percutaneous Coronary Intervention Market Share (2019-2020)
Table 65. India Percutaneous Coronary Intervention Market Size by Type (2015-2020) (Million US$)
Table 66. India Percutaneous Coronary Intervention Market Share by Type (2015-2020)
Table 67. India Percutaneous Coronary Intervention Market Size by Application (2015-2020) (Million US$)
Table 68. India Percutaneous Coronary Intervention Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Percutaneous Coronary Intervention Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Percutaneous Coronary Intervention Market Share (2019-2020)
Table 71. Central & South America Percutaneous Coronary Intervention Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Percutaneous Coronary Intervention Market Share by Type (2015-2020)
Table 73. Central & South America Percutaneous Coronary Intervention Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Percutaneous Coronary Intervention Market Share by Application (2015-2020)
Table 75. Abbott Vascular Company Details
Table 76. Abbott Vascular Business Overview
Table 77. Abbott Vascular Product
Table 78. Abbott Vascular Revenue in Percutaneous Coronary Intervention Business (2015-2020) (Million US$)
Table 79. Abbott Vascular Recent Development
Table 80. Svelte Medical Company Details
Table 81. Svelte Medical Business Overview
Table 82. Svelte Medical Product
Table 83. Svelte Medical Revenue in Percutaneous Coronary Intervention Business (2015-2020) (Million US$)
Table 84. Svelte Medical Recent Development
Table 85. Medtronic Company Details
Table 86. Medtronic Business Overview
Table 87. Medtronic Product
Table 88. Medtronic Revenue in Percutaneous Coronary Intervention Business (2015-2020) (Million US$)
Table 89. Medtronic Recent Development
Table 90. Boston Scientific Company Details
Table 91. Boston Scientific Business Overview
Table 92. Boston Scientific Product
Table 93. Boston Scientific Revenue in Percutaneous Coronary Intervention Business (2015-2020) (Million US$)
Table 94. Boston Scientific Recent Development
Table 95. Sysmetis Company Details
Table 96. Sysmetis Business Overview
Table 97. Sysmetis Product
Table 98. Sysmetis Revenue in Percutaneous Coronary Intervention Business (2015-2020) (Million US$)
Table 99. Sysmetis Recent Development
Table 100. Cardiac Dimensions Company Details
Table 101. Cardiac Dimensions Business Overview
Table 102. Cardiac Dimensions Product
Table 103. Cardiac Dimensions Revenue in Percutaneous Coronary Intervention Business (2015-2020) (Million US$)
Table 104. Cardiac Dimensions Recent Development
Table 105. Edwards Lifesciences Company Details
Table 106. Edwards Lifesciences Business Overview
Table 107. Edwards Lifesciences Product
Table 108. Edwards Lifesciences Revenue in Percutaneous Coronary Intervention Business (2015-2020) (Million US$)
Table 109. Edwards Lifesciences Recent Development
Table 110. Acrostak Business Overview
Table 111. Acrostak Product
Table 112. Acrostak Company Details
Table 113. Acrostak Revenue in Percutaneous Coronary Intervention Business (2015-2020) (Million US$)
Table 114. Acrostak Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Percutaneous Coronary Intervention Market Share by Type: 2020 VS 2026
Figure 2. Drug-Eluting Stents Features
Figure 3. Bare Metal Stents Features
Figure 4. Bioresorbable Stents Features
Figure 5. Global Percutaneous Coronary Intervention Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Healthcare Centers Case Studies
Figure 8. Neurological Research Centers Case Studies
Figure 9. Percutaneous Coronary Intervention Report Years Considered
Figure 10. Global Percutaneous Coronary Intervention Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Percutaneous Coronary Intervention Market Share by Regions: 2020 VS 2026
Figure 12. Global Percutaneous Coronary Intervention Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Percutaneous Coronary Intervention Market Share by Players in 2019
Figure 15. Global Top Percutaneous Coronary Intervention Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Percutaneous Coronary Intervention as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Percutaneous Coronary Intervention Revenue in 2019
Figure 17. North America Percutaneous Coronary Intervention Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Percutaneous Coronary Intervention Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Percutaneous Coronary Intervention Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Percutaneous Coronary Intervention Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Percutaneous Coronary Intervention Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Percutaneous Coronary Intervention Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Percutaneous Coronary Intervention Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
生体吸収性冠動脈ステントの世界市場（～2026年） Placement of these bioresorbable devices enable individuals to live with a normal functioning artery as well as the option to undergo an angioplasty in their later years. While still in development stage, the pediatric patient cohort with genetic coronary conditions are a viable target for these ful…- 経皮経管冠動脈形成術（PTCA）製品の世界市場（～2026年） Percutaneous transluminal coronary angioplasty (PTCA) is a minimally invasive procedure to open up blocked coronary arteries, allowing blood to circulate unobstructed to the heart muscle. Market Analysis and Insights: Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market The g…
- 薬剤溶出性生体吸収性ステントの世界市場（～2026年） Market Analysis and Insights: Global Drug-Eluting Bioabsorbable Stents Market The global Drug-Eluting Bioabsorbable Stents market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Drug-Eluting Bioabsorbable Stents Scope and Mar…
- 経皮的腎結石切除システムの世界市場（～2026年） Percutaneous nephrolithotomy (PCNL) is the surgical standard for treating large or complex renal stones. The complexity of the stone treated can be quantified using a variety of validated nephrolithometry classification systems. Increasing familiarity with the supine approach to PCNL has enabled sim…
- 歯科手術介入サービスの世界市場（～2026年） The dental surgical intervention involves a number of medical procedures that involve modifying or surgery of teeth and jaw bones. Dental surgeries are usually performed by qualified oral surgeons. Dental surgeries include cosmetic dental surgeries for correcting the misalignment of jaws, dental imp…